Product Code: GVR-1-68038-219-8
Disposable Syringes Market Growth & Trends:
The global disposable syringes market size is expected to reach USD 22.81 billion by 2030, registering a CAGR of 6.2% from 2023 to 2030, according to a new report by Grand View Research, Inc. The market growth is primarily driven by factors, such as a rise in technological advancements and a high incidence of obesity. Moreover, the increasing adoption of safety syringes and prevalence of diabetes drive market growth. Leading manufacturers are focusing on technological innovations and developing advanced products to gain substantial market shares. Increasing prevalence of chronic disorders, such as diabetes, can be managed by self-injecting medication. Growing cases of chronic diseases and a rising number of vaccinations that make extensive use of syringes, such as single-use and disposable syringes, are boosting market growth.
According to the International Diabetes Federation (IDF) Diabetics Atlas, the diabetic population is anticipated to grow by 46.0% reaching 643 million (1 in 9 adults) by 2030, and likely to majorly rise in middle-income countries, as compared to the developed countries. North America dominated the market in 2022 with a share of over 40%. MEA has the highest prevalence of diabetes in countries like Kuwait, Saudi Arabia, and Bahrain; thus, the region is anticipated to register the fastest CAGR of 6.9% from 2023 to 2030. Moreover, the presence of untapped opportunities in the emerging economies of Saudi Arabia and Kuwait will support regional market growth.
Disposable Syringes Market Report Highlights:
- The conventional syringes segment accounted for the largest share of around 53% in 2022. The use of injection and auto-injectors comprises the use of needles. Conventional syringes are the most practiced and used syringes in homecare settings. For instance, B.D.'s conventional syringes and needles range, the conventional disposable syringes guarantee protection for the patient receiving it. Such factors are likely to drive segment growth
- The safety syringes segment is estimated to register the fastest CAGR of 6.4% from 2023 to 2030. Safety syringes are required for most diagnostic and therapeutic approaches for chronic diseases since they are essential during medication administration and tests, resulting in rising product demand. In 2019, Japanese firm Morimoto Pharma launched a S.A.F.E. Syringe Kit vial comprising pre-attached needle syringes and a tube-shaped container into an innovative synergistic design. Such innovations are expected to ease product usage for healthcare workers
- The hospital end-use segment accounted for the largest revenue share of over 50% in 2022 due to studies being meticulously designed to maximize the chances of detecting meaningful treatment. The demand for dispensing syringes in hospitals continues to rise. Prefilled and disposable syringes are becoming increasingly common in some European states due to the use of prefilled syringes in ICUs and operating theaters
Table of Contents
Chapter 1 Methodology And Scope
- 1.1 Market Segmentation
- 1.2 Research Methodology
- 1.3 Information Procurement
- 1.3.1 Purchased Database
- 1.3.2 Gvr's Internal Database
- 1.3.3 Secondary Sources
- 1.3.4 Primary Research
- 1.4 Information Or Data Analysis
- 1.4.1 Data Analysis Models
- 1.5 Market Formulation & Validation
- 1.6 Model Details
- 1.6.1 Commodity Flow Analysis
- 1.6.1.1 Commodity Flow Analysis (Model 1)
- 1.6.1.1.1 Approach 1: Commodity Flow Approach
- 1.7 List Of Secondary Sources
- 1.8 List Of Abbreviations
- 1.9 Objectives
- 1.9.1 Objective 1
- 1.9.2 Objective 2
- 1.9.3 Objective 3
Chapter 2 Executive Summary
- 2.1 Market Outlook
- 2.1.1 Regional Insights
- 2.1.2 Competitive Landscape
- 2.2 Market Snapshot
- 2.3 Segment Snapshot
- 2.4 Segment Snapshot
- 2.5 Competitive Landscape
Chapter 3 Disposable Syringes Market Variables And Trends
- 3.1 Market Dynamics
- 3.1.1 Market Driver Impact Analysis
- 3.1.1.1 Growing Prevalence Of Chronic Disorders
- 3.1.1.2 Increasing Adoption Of Safety Syringes
- 3.1.2 Market Restraint Impact Analysis
- 3.1.2.1 Stringent Regulatory Policies And Regulations
- 3.1.3 Market Opportunities Impact Analysis
- 3.1.3.1 Increasing Demand Of Injectable Drugs
- 3.1.4 Market Challenges Impact Analysis
- 3.2 Industry Analysis Tools
- 3.2.1 Porter's Analysis
- 3.2.2 Macroeconomic Analysis
Chapter 4 Disposable Syringes Market: Syringe Type Analysis
- 4.1 Syringe Type Movement Analysis & Market Share, 2022 & 2030
- 4.2 Disposable Syringes Market Estimates & Forecast, By Syringe Type (USD Million)
- 4.3 Market Size & Forecasts And Trend Analysis, 2018 To 2030 For The Syringe Type
- 4.3.1 Conventional Syringes
- 4.3.1.1 Conventional Syringes Market, 2018 - 2030 (USD Million)
- 4.3.2 Safety Syringes
- 4.3.2.1 Safety Syringes Market, 2018 - 2030 (USD Million)
- 4.3.2.2 Retractable Safety Syringes
- 4.3.2.2.1 Retractable Safety Syringes Market, 2018 - 2030 (USD Million)
- 4.3.2.3 Non-Retractable Safety Syringes
- 4.3.2.3.1 Non-Retractable Safety Syringes Market, 2018 - 2030 (USD Million)
Chapter 5 Disposable Syringes Market: End-Use Analysis
- 5.1 End Use Movement Analysis & Market Share, 2022 & 2030
- 5.2 Disposable Syringes Market Estimates & Forecast, By End Use (USD Million)
- 5.3 Market Size & Forecasts And Trend Analysis, 2018 To 2030 For The End Use
- 5.3.1 Hospital
- 5.3.1.1 Hospital Market, 2018 - 2030 (USD Million)
- 5.3.2 Outpatient Facilities
- 5.3.2.1 Outpatient Facilities Market, 2018 - 2030 (USD Million)
- 5.3.3 Research And Manufacturing
- 5.3.3.1 Research And Manufacturing Market, 2018 - 2030 (USD Million)
Chapter 6 Disposable Syringes Market: Regional Estimates & Trend Analysis
- 6.1 Disposable Syringes Market: Regional Outlook
- 6.2 North America
- 6.2.1 North America Disposable Syringes Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 6.2.2 U.S.
- 6.2.2.1 Key Country Dynamics
- 6.2.2.2 U.S. Disposable Syringes Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.2.3 Canada
- 6.2.3.1 Key Country Dynamics
- 6.2.3.2 Canada Disposable Syringes Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.3 Europe
- 6.3.1. Europe Disposable Syringes Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.3.2 Uk
- 6.3.2.1 Key Country Dynamics
- 6.3.2.2 Uk Disposable Syringes Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.3.3 Germany
- 6.3.3.1 Key Country Dynamics
- 6.3.3.2 Germany Disposable Syringes Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.3.4 France
- 6.3.4.1 Key Country Dynamics
- 6.3.4.2 France Disposable Syringes Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.3.5 Italy
- 6.3.5.1 Key Country Dynamics
- 6.3.5.2 Italy Disposable Syringes Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.3.6 Spain
- 6.3.6.1 Key Country Dynamics
- 6.3.6.2 Spain Disposable Syringes Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.3.7 Sweden
- 6.3.7.1 Key Country Dynamics
- 6.3.7.2 Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.3.8 Denmark
- 6.3.8.1 Key Country Dynamics
- 6.3.8.2 Denmark Disposable Syringes Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.3.9 Norway
- 6.3.9.1 Key Country Dynamics
- 6.3.9.2 Norway Disposable Syringes Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.4 Asia Pacific
- 6.4.1. Asia Pacific Disposable Syringes Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.4.2 Japan
- 6.4.2.1 Key Country Dynamics
- 6.4.2.2 Japan Disposable Syringes Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.4.3 China
- 6.4.3.1 Key Country Dynamics
- 6.4.3.2 China Disposable Syringes Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.4.4 India
- 6.4.4.1 Key Country Dynamics
- 6.4.4.2 India Disposable Syringes Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.4.5 Australia
- 6.4.5.1 Key Country Dynamics
- 6.4.5.2 Australia Disposable Syringes Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.4.6 South Korea
- 6.4.6.1 Key Country Dynamics
- 6.4.6.2 South Korea Disposable Syringes Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.4.7 Thailand
- 6.4.7.1 Key Country Dynamics
- 6.4.7.2 Thailand Disposable Syringes Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.5 Latin America
- 6.5.1. Latin America Disposable Syringes Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.5.2 Brazil
- 6.5.2.1 Key Country Dynamics
- 6.5.2.2 Brazil Disposable Syringes Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.5.3 Mexico
- 6.5.3.1 Key Country Dynamics
- 6.5.3.2 Mexico Disposable Syringes Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.5.4 Argentina
- 6.5.4.1 Key Country Dynamics
- 6.5.4.2 Argentina Disposable Syringes Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.6 Middle East & Africa
- 6.6.1. Middle East & Africa Disposable Syringes Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.6.2 South Africa
- 6.6.2.1 Key Country Dynamics
- 6.6.2.2 South Africa Disposable Syringes Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.6.3 Saudi Arabia
- 6.6.3.1 Key Country Dynamics
- 6.6.4 UAE
- 6.6.4.1 Key Country Dynamics
- 6.6.4.2 UAE Disposable Syringes Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.6.5 Kuwait
- 6.6.5.1 Key Country Dynamics
- 6.6.5.2 Kuwait Disposable Syringes Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 7 Competitive Analysis
- 7.1 Company Categorization
- 7.1. 1. Recent Developments & Impact Analysis, By Key Market Participants
- 7.2. Market Participant Categorization
- 7.2.1. Medtronic
- 7.2.1.1. Company Overview
- 7.2.1.2. Financial Performance
- 7.2.1.3. Product Benchmarking
- 7.2.1.4. Strategic Initiatives
- 7.2.2. Nipro Corporation
- 7.2.2.1. Company Overview
- 7.2.2.2. Financial Performance
- 7.2.2.3. Product Benchmarking
- 7.2.2.4. Strategic Initiatives
- 7.2.3. Fresenius Kabi Ag
- 7.2.3.1. Company Overview
- 7.2.3.2. Financial Performance
- 7.2.3.3. Product Benchmarking
- 7.2.3.4. Strategic Initiatives
- 7.2.4. Baxter
- 7.2.4.1. Company Overview
- 7.2.4.2. Financial Performance
- 7.2.4.3. Product Benchmarking
- 7.2.4.4. Strategic Initiatives
- 7.2.5. Braun Medical, Inc.
- 7.2.5.1. Company Overview
- 7.2.5.2. Financial Performance
- 7.2.5.3. Product Benchmarking
- 7.2.5.4. Strategic Initiatives
- 7.2.6. Becton, Dickinson And Company (Bd)
- 7.2.6.1. Company Overview
- 7.2.6.2. Financial Performance
- 7.2.6.3. Product Benchmarking
- 7.2.6.4. Strategic Initiatives
- 7.2.7. Flextronics International Vita Needle Company
- 7.2.7.1. Company Overview
- 7.2.7.2. Financial Performance
- 7.2.7.3. Product Benchmarking
- 7.2.7.4. Strategic Initiatives
- 7.2.8. Terumo Corporation
- 7.2.8.1. Company Overview
- 7.2.8.2. Financial Performance
- 7.2.8.3. Product Benchmarking
- 7.2.8.4. Strategic Initiatives
- 7.2.9. Novo Nordisk
- 7.2.9.1. Company Overview
- 7.2.9.2. Financial Performance
- 7.2.9.3. Product Benchmarking
- 7.2.9.4. Strategic Initiatives
- 7.2.10. Ultimed, Inc.
- 7.2.10.1. Company Overview
- 7.2.10.2. Financial Performance
- 7.2.10.3. Product Benchmarking
- 7.2.10.4. Strategic Initiatives
- 7.2.11. Henke-Sass Wolf
- 7.2.11.1. Company Overview
- 7.2.11.2. Financial Performance
- 7.2.11.3. Product Benchmarking
- 7.2.11.4. Strategic Initiatives
- 7.2.12. Retractable Technologies, Inc
- 7.2.12.1. Company Overview
- 7.2.12.2. Financial Performance
- 7.2.12.3. Product Benchmarking
- 7.2.12.4. Strategic Initiatives
- 7.3 Participant's Overview
- 7.4 Financial Performance
- 7.4 Product Benchmarking
- 7.6 Strategy Mapping
- 7.6.1 Mergers & Acquisitions
- 7.6.2 New Product Launch
- 7.6.3 Partnerships & Collaborations
- 7.6.4 Geographical Expansion
Chapter 8 Analyst Perspective